| 1 |
Lu H, Cao W, Zhang L, Yang L, Bi X, Lin Y, Deng W, Jiang T, Sun F, Zeng Z, Lu Y, Zhang L, Liu R, Gao Y, Wu S, Hao H, Chen X, Hu L, Xu M, Xiong Q, Dong J, Song R, Li M, Xie Y. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity. Front Immunol 2023;14:1122048. [PMID: 36875136 DOI: 10.3389/fimmu.2023.1122048] [Reference Citation Analysis]
|
| 2 |
Anand P, Singh S, Schelonka RL, Tekleab AM, Upadhyay A. Hepatitis B Infections in Neonates. Newborn 2022;1:368-375. [DOI: 10.5005/jp-journals-11002-0049] [Reference Citation Analysis]
|
| 3 |
Yang N, Lei L, Meng Y, Zhou N, Shi L, Hu M. Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree. Front Public Health 2022;10:662442. [DOI: 10.3389/fpubh.2022.662442] [Reference Citation Analysis]
|
| 4 |
Goswami R, Pavon CG, Miller IG, Berendam SJ, Williams CA, Rosenthal D, Gross M, Phan C, Byrd A, Pollara J, Permar SR, Fouda GG. Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.849995] [Reference Citation Analysis]
|
| 5 |
Mao L, Zhu AK, Liu J. Correlation between postpartum unsatisfied needs of hepatitis B virus carriers and childcare competence. Shijie Huaren Xiaohua Zazhi 2021; 29(24): 1434-1440 [DOI: 10.11569/wcjd.v29.i24.1434] [Reference Citation Analysis]
|
| 6 |
Lin Y, Liu Y, Xu D, Guo F, Zhang W, Zhang Y, Bai G. HBxAg promotes HBV replication and EGFR activation in human placental trophoblasts. Exp Ther Med 2021;22:1211. [PMID: 34584556 DOI: 10.3892/etm.2021.10645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Eleje GU, Akaba GO, Mbachu II, Rabiu A, Loto OM, Usman HA, Fiebai PO, Chukwuanukwu RC, Joe-Ikechebelu NN, Nwankwo CH, Kalu SO, Onubogu CU, Ogbuagu CN, Chukwurah SN, Uzochukwu CE, Inuyomi SO, Adesoji BA, Ogwaluonye UC, Nweje SI, Egeonu RO, Igue OE, Jibuaku CH, Aja PO, Chidozie CP, Ibrahim HS, Aliyu FE, Numan AI, Okoro OD, Omoruyi SA, Oppah IC, Anyang UI, Ahmed A, Umeononihu OS, Umeh EO, Emeka EA, Onwuegbuna AA, Igbodike EP, Ajuba IC, Yakasai IA, Ezechi OC, Ikechebelu JI; Triplex Infection in Pregnancy Collaboration Group. Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study. Ther Adv Vaccines Immunother 2021;9:25151355211032595. [PMID: 34377929 DOI: 10.1177/25151355211032595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Veronese P, Dodi I, Esposito S, Indolfi G. Prevention of vertical transmission of hepatitis B virus infection. World J Gastroenterol 2021; 27(26): 4182-4193 [PMID: 34326618 DOI: 10.3748/wjg.v27.i26.4182] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 9 |
Hong J, Choi Y, Choi Y, Lee J, Hong HJ. Epitope-Paratope Interaction of a Neutralizing Human Anti-Hepatitis B Virus PreS1 Antibody That Recognizes the Receptor-Binding Motif. Vaccines (Basel) 2021;9:754. [PMID: 34358170 DOI: 10.3390/vaccines9070754] [Reference Citation Analysis]
|
| 10 |
Narang K, Cheek EH, Enninga EAL, Theiler RN. Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives. Int J Mol Sci 2021;22:2921. [PMID: 33805739 DOI: 10.3390/ijms22062921] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 11 |
Eleje GU, Mbachu II, Ogwaluonye UC, Kalu SO, Onubogu CU, Nweje SI, Uzochukwu CE, Nwankwo CH, Fiebai PO, Loto OM, Akaba GO, Usman HA, Rabiu A, Egeonu RO, Igue OE, Adesoji BA, Jibuaku CH, Aja PO, Chidozie CP, Ibrahim HS, Aliyu FE, Numan AI, Okoro OD, Omoruyi SA, Oppah IC, Anyang UI, Ahmed A, Chukwurah SN, Umeononihu OS, Chukwuanukwu RC, Umeh EO, Emeka EA, Ogbuagu CN, Yakasai IA, Ezechi OC, Ikechebelu JI; Triplex infection in pregnancy collaboration group. Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol. Reprod Health 2020;17:144. [PMID: 32977846 DOI: 10.1186/s12978-020-00995-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Ugwu EO, Eleje GU, Ugwu AO, Nwagha UI, Ikechebelu JI, Umeh UA, Okafor HU. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus. Cochrane Database of Systematic Reviews 2020. [DOI: 10.1002/14651858.cd013653] [Reference Citation Analysis]
|
| 13 |
Herrscher C, Roingeard P, Blanchard E. Hepatitis B Virus Entry into Cells. Cells 2020;9:E1486. [PMID: 32570893 DOI: 10.3390/cells9061486] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 14 |
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019;16:589-604. [PMID: 31439937 DOI: 10.1038/s41575-019-0186-y] [Cited by in Crossref: 1504] [Cited by in F6Publishing: 1533] [Article Influence: 376.0] [Reference Citation Analysis]
|
| 15 |
Jourdain G, Ngo-Giang-Huong N, Khamduang W. Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications. Infect Drug Resist 2019;12:977-87. [PMID: 31118703 DOI: 10.2147/IDR.S171695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018;10:585-94. [PMID: 30310536 DOI: 10.4254/wjh.v10.i9.585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 17 |
Pierce-williams RAM, Sheffield JS. Hepatitis B in the Perinatal Period. Neonatal Infections 2018. [DOI: 10.1007/978-3-319-90038-4_11] [Reference Citation Analysis]
|
| 18 |
What are the benefits and harms of hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus? Cochrane Clinical Answers 2017. [DOI: 10.1002/cca.1678] [Reference Citation Analysis]
|
| 19 |
Brooks J, Gelson W, Rushbrook SM. Therapeutic advances in the management of chronic hepatitis B infection. Ther Adv Chronic Dis 2013;4:157-66. [PMID: 23819019 DOI: 10.1177/2040622313484647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
